Silence Therapeutics Plc (SLN) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Number of Phlebotomy-Dependent Polycythemia Vera Patients Enrolled | 48.00 | FY2025-Q4 |
| Research Collaboration Income revenue | 159K | FY2025-Q3 |
| GB revenue | 422K | FY2026-Q1 |
Back to SLN overview · SLN earnings · SLN holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.